http://www.sciton.com Latest news on aesthetic treatment systems Sciton announced the pending availability of the new Contour Tunable Resurfacing Laser (TRL) this fall. The TRL is a significant improvement of the Contour dual-pulse mode laser from Sciton, Inc. (Palo Alto, Calif.) with the ability to precisely adjust ablative depth and thermal coagulation depth for emulating any ablative or nonablative laser on the market. "This system eliminates the need for all existing single modality lasers and for the first time will allow doctors to titrate the precise amount of ablation and coagulation needed for each area treated". Sciton announced at the AAD in Washington D.C. that it will be releasing the new ProFractional handpiece in April 2007. The much anticipated release will bring to the market innovative fractional resurfacing technology for the treatment of aging skin, wrinkles and acne scars. Palo Alto CA - November 21, 2006. Sciton, the leader in resurfacing laser technologies, announced a significant step in the development of fractional laser treatment with its new ProFractional technology. Sciton is developing ProFractional as a module that can be added to its Profile laser platform, which is currently used for procedures such as the MicroLaserPeel, laser resurfacing, non-ablative laser skin treatments, scar reduction, and other aesthetic laser procedures. Sciton announced that the new ProLipo™ laser module received clearance from the U.S. Food and Drug Administration for laser-assisted lipolysis, and its BBL™ broadband pulsed light received clearance for the treatment of wrinkles. Sciton announced the immediate availability of the SkinTyte ST Accessory for skin tightening. Forecast to grow at a rate of 50% for the next two year, skin tightening is predicted to be one of the fastest growing aesthetic market segments. The new SkinTyte ST Accessory is used for selective photocoagulation of soft tissue in conjunction with an integrated thermo-electric cooler to cool the epidermis prior-to, during, and after treatment, reducing discomfort and minimizing thermal injury to non-target skin and skin structures. This technique selectively targets and treats dermal collagen. The result is partial coagulation and contraction of collagen. With SkinTyte, practitioners can quickly add this procedure to their practice by simply attaching the accessory to their BBL. The ease with which the BBL can switch quickly from this to other modalities greatly facilitates the ability for practitioners to offer combination procedures to their patients for advanced outcomes and increased patient satisfaction. to offer combination procedures to their patients for advanced outcomes and increased patient satisfaction. Dr. Jason Pozner, a plastic surgeon located in Boca Raton, FL has experience with the BBL and ST accessory. "Currently I like to use the BBL SkinTyte device for large surface area treatments, such as legs, arms and abdomens. My experience is that patients find it more comfortable than other skin tightening treatments, and patients are very happy with the results they are seeing". The large spot size of the BBL, 15 X 45mm, enables quick treatment of large surface areas. The BBL SkinTyte has the industry's largest treatment area for this treatment and is an ideal device for enabling practitioners to further increase the procedural profitability of their practice. For smaller surface areas, and hard to reach areas, the BBL has small spot, magnetically attached adapters so that BBL stays true to form in not requiring an expensive handpiece purchase further elevating the value of the BBL above other intense pulsed light systems available today. Sciton also announced significant advancements in the development of its ProFractional technology. Described as the delivery of small spots scanned over the skin's surface, early clinical data suggests that ProFractional will have significant advantages over any other currently available fractionated device. ProFractional is designed to have proprietary control features not currently available in any device. Dr. Pozner is involved in early clinical studies of the ProFractional device. "I'm extremely excited about the early results I'm seeing with the ProFractional", stated Dr. Pozner. "Its still very early in the development, but already the ProFractional looks like it may become a significant part of my practice", Dr Pozner added.